Communiqués Haleon plc Nyse

Actions

HLN

US4055521003

Marché Fermé - Nyse Autres places de cotation 22:00:02 17/06/2024			Pré-ouverture 15:18:07
8,37 ^USD	-0,24%		8,38	+0,12%

05/06	HALEON PLC : Berenberg Bank revoit son opinion à la hausse	ZM
05/06	Haleon : en hausse, Berenberg initie le titre à l'achat	CF

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Haleon : Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them - Form 6-K	23/05	PU
Haleon Canada & GlobalMedic Launch Haleon Health Trailer	14/05	AQ
EMTN programme: publication of base prospectus - Form 6-K	07/05	PU
Haleon : announces changes to the Board - Form 6-K	02/05	PU
Haleon : 2024 Q1 Trading Statement	01/05	PU
Healthcare group Haleon set to cut over 400 jobs and close its only UK factory	01/05	AQ
Haleon plc: Notice of Annual General Meeting (AGM) - Form 6-K	12/04	PU
Haleon : Voting Instruction Card 2024	12/04	PU
Haleon : Notice of Meeting 2024	12/04	PU
Collaboration for Healthier Lives Launches Preventative Health Playbook	08/04	AQ
Haleon : Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them - Form 6-K	03/04	PU
Haleon : Final prospectus supplement filed with the SEC	20/03	PU
Haleon to buy shares from Pfizer as US pharma giant reduces its stake	19/03	AQ
Haleon : Preliminary prospectus supplement filed with SEC	18/03	PU
Haleon : Share Repurchase Deed between Haleon plc and Pfizer Inc., dated September 11, 2023 - Form 6-K	18/03	PU
Haleon : Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them - Form 6-K	14/03	PU
Haleon : Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them - Form 6-K	12/03	PU
Robitussin maker recalls several lots of cough syrup due to possible high levels of yeast	25/01	AQ
Possible microbial contamination spurs cough syrup recall	25/01	AQ
Advil presents an in-game solution to fight gaming headaches	16/01	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

HALEON : Rentabilité supérieure au 1er trimestre ; prévisions inchangées

Le 01 mai 2024 à 18:20